Matthew E Levison Selected Research

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

6/2005	Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.
12/2004	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.
10/2004	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew E Levison Research Topics

Disease

4	Endocarditis 10/2015 - 06/2005
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 06/2005 - 10/2004
2	Infections 01/2010 - 01/2006
2	Fever (Fevers) 12/2004 - 10/2004
2	Heart Diseases (Heart Disease) 12/2004 - 10/2004
1	Urinary Tract Infections (Urinary Tract Infection) 04/2013
1	Meningitis 12/2009
1	Necrotizing Pneumonia 01/2006
1	Soft Tissue Infections 01/2006
1	Communicable Diseases (Infectious Diseases) 06/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2005
1	Stroke (Strokes) 06/2005
1	Rheumatic Fever (Acute Articular Rheumatism) 06/2005

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 08/2014 - 01/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004 - 10/2004
2	AnticoagulantsIBA 12/2004 - 10/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2004 - 10/2004
2	Intravenous Immunoglobulins (IVIG)FDA Link 12/2004 - 10/2004
2	Abciximab (ReoPro)FDA Link 12/2004 - 10/2004
2	gamma-Globulins (gamma-Globulin)IBA 12/2004 - 10/2004
1	C-Reactive ProteinIBA 08/2014
1	beta-LactamsIBA 01/2006
1	Virulence Factors (Pathogenicity Factors)IBA 01/2006
1	Panton-Valentine leukocidinIBA 01/2006

Therapy/Procedure

8	Therapeutics 10/2015 - 10/2004
2	Physical Therapy Modalities (Physical Therapy Technique) 12/2004 - 10/2004
2	Retreatment 12/2004 - 10/2004
1	Antibiotic Prophylaxis 01/2010
1	Critical Care (Surgical Intensive Care) 06/2005
1	Anesthesia 06/2005